Cancers 2010, 2(3), 1617-1628; doi:10.3390/cancers2031617
Review

ZEB1 in Pancreatic Cancer

email, email and * email
Received: 30 June 2010; in revised form: 16 August 2010 / Accepted: 17 August 2010 / Published: 18 August 2010
(This article belongs to the Special Issue Pancreatic Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Pancreatic cancer is one of the most malignant human neoplasias. On the molecular level, epithelial-mesenchymal transition (EMT) has been demonstrated to contribute to the malignant phenotype of pancreatic cancer cells. ZEB1 is a transcriptional repressor that has been identified as an inducer of EMT. A negative feedback loop between ZEB1 and microRNA-200c has been shown to regulate this EMT induction in various models. With respect to pancreatic cancer, primary effects of EMT comprise increased local and distant tumor cell dissemination. Another recently described feature of the EMT is the acquisition of cancer stem cell traits. For pancreatic cancer cells, antagonism between ZEB1 and stemness-inhibiting micro-RNAs has been demonstrated to contribute to this process, providing experimental support for the migrating cancer stem cell (MCSC) hypothesis. ZEB1 has also been shown to be associated with drug resistance of pancreatic cancer cells. This article reviews the biological functions of ZEB1 with a focus on pancreatic cancer.
Keywords: pancreatic cancer; ZEB1; EMT; MCSC
PDF Full-text Download PDF Full-Text [297 KB, uploaded 18 August 2010 13:38 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Wellner, U.; Brabletz, T.; Keck, T. ZEB1 in Pancreatic Cancer. Cancers 2010, 2, 1617-1628.

AMA Style

Wellner U, Brabletz T, Keck T. ZEB1 in Pancreatic Cancer. Cancers. 2010; 2(3):1617-1628.

Chicago/Turabian Style

Wellner, Ulrich; Brabletz, Thomas; Keck, Tobias. 2010. "ZEB1 in Pancreatic Cancer." Cancers 2, no. 3: 1617-1628.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert